Article
Allogeneic hematopoietic stem cell transplantation in a case of congenital sideroblastic anemia with SLC25A38 mutation
2024-01-31
Abstract excerpt
Congenital sideroblastic anemia (CSA) is a rare genetic disease. SLC25A38 encodes a member of the mitochondrial membrane carrier protein family. Mutations in SLC25A38 have been found to be an important cause of transfusion-dependent CSA. Evidence-based medical treatment guidelines for CSA remain lacking, and hematopoietic stem cell transplantation (HSCT) is currently the only proven curative therapy for this disea...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 56c5e8f8-c06f-5e28-b0b5-66b56a26eb57
- DOI
- 10.22541/au.170668122.21111241/v1
